Ester Boix

Title: Ester Boix: Innovator in Recombinant Protein Technology

Introduction

Ester Boix is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant proteins with therapeutic applications. With a total of 2 patents, his work focuses on innovative methods for producing cytotoxic ribonucleolytic proteins.

Latest Patents

Ester Boix's latest patents include a mutant form of a cytotoxic ribonucleolytic protein that allows for production by recombinant methods. This invention provides recombinant Onc (rOnc) compositions and methods. The recombinant Onc proteins feature an amino terminal methionine, which facilitates recombinant production in bacterial host cells. Cleaving the amino terminal methionine reveals the amino terminal glutamine of the polypeptide, which is crucial for its functionality. The Onc polypeptide possesses an amino terminal glutamine, and the cyclization of this residue to a pyroglutamyl form results in rOnc polypeptides and proteins that exhibit anti-cancer and anti-viral activity.

Career Highlights

Ester Boix is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to explore and develop groundbreaking technologies in the field of recombinant proteins.

Collaborations

Ester has collaborated with notable scientists such as Richard J. Youle and Veena M. Vasandani. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.

Conclusion

Ester Boix is a key figure in the realm of recombinant protein technology, with a focus on developing therapeutic solutions for cancer and viral diseases. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving health outcomes.